Glioblastoma and Other Primary Brain Malignancies in Adults

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

(2022) Daniel J. Brat et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study

(2022) Georgios Mantziaris et al.   JOURNAL OF NEURO-ONCOLOGY

Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma

(2022) Ingo K. Mellinghoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Do Cell Phones Cause Brain Tumors? Another Piece of the Puzzle

(2022) Douglas L Weed   JNCI-Journal of the National Cancer Institute

Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study

(2022) Joachim Schüz et al.   JNCI-Journal of the National Cancer Institute

Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study

(2022) Lauren Reed-Guy et al.   NEURO-ONCOLOGY

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

(2022) Antonio Omuro et al.   NEURO-ONCOLOGY

Ependymoma: Evaluation and Management Updates

(2022) Roberta Rudà et al.   Current Oncology Reports

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study

(2022) Caroline Houillier et al.   JOURNAL OF CLINICAL ONCOLOGY

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

(2022) Andrew B. Lassman et al.   JOURNAL OF CLINICAL ONCOLOGY

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

(2022) Tomoki Todo et al.   NATURE MEDICINE

European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL)

(2022) Khê Hoang-Xuan et al.   NEURO-ONCOLOGY

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

(2022) Jaime Gállego Pérez-Larraya et al.   NEW ENGLAND JOURNAL OF MEDICINE

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

(2022) Christina I. Tsien et al.   JOURNAL OF CLINICAL ONCOLOGY

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

(2022) Priscilla K. Brastianos et al.   JOURNAL OF CLINICAL ONCOLOGY

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

(2022) Julie J Miller et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019

(2022) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies

(2021) Andrew W. Swartz et al.   ONCOLOGIST

Evidence-based recommendations on categories for extent of resection in diffuse glioma

(2021) Philipp Karschnia et al.   EUROPEAN JOURNAL OF CANCER

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

(2021) Martin J van den Bent et al.   LANCET ONCOLOGY

A vaccine targeting mutant IDH1 in newly diagnosed glioma

(2021) Michael Platten et al.   NATURE

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

(2021) Ingo K. Mellinghoff et al.   CLINICAL CANCER RESEARCH

Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma

(2021) Miyabi Saito et al.   JOURNAL OF NEURO-ONCOLOGY

Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results

(2021) Wenya Linda Bi et al.   NEURO-ONCOLOGY

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors

(2021) Tobias Walbert et al.   NEURO-ONCOLOGY

Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?

(2021) Jasmin Jo et al.   NEURO-ONCOLOGY

A Molecularly Integrated Grade for Meningioma

(2021) Joseph Driver et al.   NEURO-ONCOLOGY

Primary Central Nervous System Lymphoma

(2021) Lauren R. Schaff et al.   BLOOD

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

(2021) Patrick Y Wen et al.   LANCET ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018

(2021) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease

(2021) Eric Jonasch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors

(2021) Angela Lee et al.   THROMBOSIS RESEARCH

Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma

(2020) Annette M. Molinaro et al.   JAMA Oncology

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions

(2020) Patrick Y Wen et al.   NEURO-ONCOLOGY

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

(2020) David A. Reardon et al.   JAMA Oncology

Optimal Management of Corticosteroids in Patients with Intracranial Malignancies

(2020) Karan S. Dixit et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma

(2020) Ingo K. Mellinghoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

(2020) Erica H. Bell et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes

(2019) Abdurrahman I. Islim et al.   JOURNAL OF NEURO-ONCOLOGY

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

(2019) Timothy F. Cloughesy et al.   NATURE MEDICINE

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

(2019) Kurt A. Schalper et al.   NATURE MEDICINE

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

(2019) Caroline Houillier et al.   JOURNAL OF CLINICAL ONCOLOGY

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

(2019) Jason Fangusaro et al.   LANCET ONCOLOGY

Genomic correlates of disease progression and treatment response in prospectively characterized gliomas

(2019) Philip Jonsson et al.   CLINICAL CANCER RESEARCH

Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma

(2019) Leon D. Kaulen et al.   JOURNAL OF NEURO-ONCOLOGY

Risk Factors For Childhood And Adult Primary Brain Tumors

(2019) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Letter: When Less is More: Dexamethasone Dosing for Brain Tumors

(2019) Mary Jane Lim-Fat et al.   NEUROSURGERY

Unknown

(2018)   CANCER

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

(2018) Annie M. Young et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

Recurrent Glioblastoma Treated with Recombinant Poliovirus

(2018) Annick Desjardins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study

(2018) Thomas Kaley et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

(2017) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

(2017) Martin J van den Bent et al.   LANCET

European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma

(2017) Andrea Pace et al.   LANCET ONCOLOGY

Surgical oncology for gliomas: the state of the art

(2017) Nader Sanai et al.   Nature Reviews Clinical Oncology

EANO guidelines for the diagnosis and treatment of ependymal tumors

(2017) Roberta Rudà et al.   NEURO-ONCOLOGY

The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades

(2017) Joe S Mendez et al.   NEURO-ONCOLOGY

Mutant IDH1 and seizures in patients with glioma

(2017) Hao Chen et al.   NEUROLOGY

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

(2017) James R. Perry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

(2017) Christian Grommes et al.   Cancer Discovery

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

(2017) Andrés J M Ferreri et al.   Lancet Haematology

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

(2016) Kristian W. Pajtler et al.   ACTA NEUROPATHOLOGICA

Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study

(2016) E. S. Amirian et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

(2016) Edward K. Avila et al.   NEURO-ONCOLOGY

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

(2016) Jan C. Buckner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recurrent venous thromboembolism in glioblastoma

(2016) Natasha Catherine Edwin et al.   THROMBOSIS RESEARCH

Association of the Extent of Resection With Survival in Glioblastoma

(2016) Timothy J. Brown et al.   JAMA Oncology

International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme

(2015) Wilson Roa et al.   JOURNAL OF CLINICAL ONCOLOGY

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States

(2015) Varun R. Kshettry et al.   NEURO-ONCOLOGY

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Quantifying the heritability of glioma using genome-wide complex trait analysis

(2015) Ben Kinnersley et al.   Scientific Reports

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

(2014) Thomas J. Kaley et al.   NEURO-ONCOLOGY

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

(2012) Gregory Cairncross et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

(2012) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

(2012) Emil Lou et al.   JOURNAL OF NEURO-ONCOLOGY

Atypical and anaplastic meningiomas treated with bevacizumab

(2012) Lakshmi Nayak et al.   JOURNAL OF NEURO-ONCOLOGY

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

(2012) David Neal Franz et al.   LANCET

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

(2012) Annika Malmström et al.   LANCET ONCOLOGY

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

(2012) Wolfgang Wick et al.   LANCET ONCOLOGY

Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review

(2012) M. Z. Braganza et al.   NEURO-ONCOLOGY

Thromboembolic disease in patients with high-grade glioma

(2012) J. R. Perry   NEURO-ONCOLOGY

Predictors of Survival among Pediatric and Adult Ependymoma Cases: A Study Using Surveillance, Epidemiology, and End Results Data from 1973 to 2007

(2012) E. Susan Amirian et al.   NEUROEPIDEMIOLOGY

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

(2010) J. R. PERRY et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Headache attributed to intracranial tumours: a prospective cohort study

(2009) L Valentinis et al.   CEPHALALGIA

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

(2009) Andrés JM Ferreri et al.   LANCET

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE